San Diego, CA -- (SBWire) -- 08/26/2021 --Axsome Therapeutics, Inc is under investigation concerning possible securities laws violations in connection with certain financial statements.
Investors who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether certain statements by Axsome Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
New York based Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States.
Axsome Therapeutics, Inc. (NASDAQ: AXSM) disclosed on August 9, 2021, that the FDA had found deficiencies with its New Drug Application (NDA) for AXS-05. The Company claimed it was attempting to determine the nature of the deficiencies, but that this announcement may delay the approval of AXS-05.
Shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) declined $74.10 per share on June 28, 2021, to as low as $19.38 per share on August 19, 2021.
Those who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shareholder Notice: Investigation over Possible Violations of Securities Laws
An investigation for investors in Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares over potential securities laws violations by Axsome Therapeutics, Inc. was announced and NASDAQ:AXSM stockholders should contact the Shareholders Foundation.